{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:21:32Z","timestamp":1790266892260,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK138021"],"award-info":[{"award-number":["R01DK138021"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005440","name":"National Institutes of Health Center for Scientific Review","doi-asserted-by":"publisher","award":["T32GM148382"],"award-info":[{"award-number":["T32GM148382"]}],"id":[{"id":"10.13039\/100005440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimie"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.biochi.2026.05.009","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T15:03:27Z","timestamp":1779980607000},"page":"40-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Gut-derived uremic toxin indoxyl sulfate and aryl hydrocarbon receptor in renal osteodystrophy"],"prefix":"10.1016","volume":"248","author":[{"suffix":"III","given":"Carl Ralph","family":"Russell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2549-0539","authenticated-orcid":false,"given":"Annabel","family":"Biruete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2944-8082","authenticated-orcid":false,"given":"Corinne","family":"Metzger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Moe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biochi.2026.05.009_bib1","article-title":"Global burden of chronic kidney disease and risk factors, 1990-2021: an update from the global burden of disease study 2021","volume":"13","author":"Wang","year":"2025","journal-title":"Front. Public Health"},{"key":"10.1016\/j.biochi.2026.05.009_bib2","first-page":"1","article-title":"Chronic kidney disease in the United States, 2021","volume":"1","year":"2021","journal-title":"CDC"},{"issue":"11","key":"10.1016\/j.biochi.2026.05.009_bib3","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.2215\/CJN.09500916","article-title":"Fractures in patients with CKD: time for action","volume":"11","author":"Moe","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.biochi.2026.05.009_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/j.ackd.2006.10.005","article-title":"Chronic kidney disease-mineral-bone disorder: a new paradigm","volume":"14","author":"Moe","year":"2007","journal-title":"Adv. Chron. Kidney Dis."},{"issue":"3","key":"10.1016\/j.biochi.2026.05.009_bib5","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.kint.2024.11.013","article-title":"Chronic kidney disease-mineral and bone disorder: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference","volume":"107","author":"Ketteler","year":"2025","journal-title":"Kidney Int."},{"issue":"10","key":"10.1016\/j.biochi.2026.05.009_bib6","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/jbmr.2862","article-title":"Hip fracture in patients with non-dialysis-requiring chronic kidney disease","volume":"31","author":"Kim","year":"2016","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.biochi.2026.05.009_bib7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.ajkd.2005.09.024","article-title":"PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis","volume":"47","author":"Danese","year":"2006","journal-title":"Am. J. Kidney Dis."},{"issue":"8","key":"10.1016\/j.biochi.2026.05.009_bib8","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.2215\/CJN.10901012","article-title":"Temporal trends in the incidence, treatment, and outcomes of hip fracture in older patients initiating dialysis in the United States","volume":"8","author":"Nair","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"10","key":"10.1016\/j.biochi.2026.05.009_bib9","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1038\/sj.ki.5000311","article-title":"Osteoporosis in hemodialysis patients revisited by bone histomorphometry: a new insight into an old problem","volume":"69","author":"Barreto","year":"2006","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.biochi.2026.05.009_bib10","first-page":"24","article-title":"The hidden cross talk between bone and tissues through bone turnover","volume":"5","author":"Gonzalez-Casaus","year":"2024","journal-title":"Adv. Lab Med."},{"issue":"5","key":"10.1016\/j.biochi.2026.05.009_bib11","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.kint.2018.08.011","article-title":"Impaired osteocyte maturation in the pathogenesis of renal osteodystrophy","volume":"94","author":"Pereira","year":"2018","journal-title":"Kidney Int."},{"key":"10.1016\/j.biochi.2026.05.009_bib12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41413-019-0051-1","article-title":"DMP1 prevents osteocyte alterations, FGF23 elevation and left ventricular hypertrophy in mice with chronic kidney disease","volume":"7","author":"Dussold","year":"2019","journal-title":"Bone Res."},{"issue":"2","key":"10.1016\/j.biochi.2026.05.009_bib13","first-page":"196","article-title":"Bone matrix mineralization and osteocyte lacunae characteristics in patients with chronic kidney disease - mineral bone disorder (CKD-MBD)","volume":"19","author":"Misof","year":"2019","journal-title":"J. Musculoskelet. Neuronal Interact."},{"key":"10.1016\/j.biochi.2026.05.009_bib14","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bone.2018.05.002","article-title":"Osteocytic perilacunar\/canalicular turnover in hemodialysis patients with high and low serum PTH levels","volume":"113","author":"Yajima","year":"2018","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.biochi.2026.05.009_bib15","first-page":"1514","article-title":"A history of uraemic toxicity and of the European Uraemic Toxin Work Group (EUTox)","volume":"14","author":"Vanholder","year":"2021","journal-title":"Clin. Kidney J."},{"issue":"8","key":"10.1016\/j.biochi.2026.05.009_bib16","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.cmet.2023.06.004","article-title":"Tryptophan metabolism in health and disease","volume":"35","author":"Xue","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.biochi.2026.05.009_bib17","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/9894238","article-title":"Kynurenine, a tryptophan metabolite that increases with age, induces muscle atrophy and lipid peroxidation","volume":"2019","author":"Kaiser","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"4","key":"10.1016\/j.biochi.2026.05.009_bib18","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF03226377","article-title":"Hepatic microsomal metabolism of indole to indoxyl, a precursor of indoxyl sulfate","volume":"26","author":"Banoglu","year":"2001","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"issue":"3","key":"10.1016\/j.biochi.2026.05.009_bib19","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/ndt\/18.3.463","article-title":"Uraemic toxins and cardiovascular disease","volume":"18","author":"Vanholder","year":"2003","journal-title":"Nephrol. Dial. Transplant."},{"issue":"7","key":"10.1016\/j.biochi.2026.05.009_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132589","article-title":"Meta-analysis of the associations of p-Cresyl sulfate (PCS) and Indoxyl Sulfate (IS) with cardiovascular events and all-cause mortality in patients with chronic renal failure","volume":"10","author":"Lin","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.biochi.2026.05.009_bib21","doi-asserted-by":"crossref","first-page":"982","DOI":"10.2215\/CJN.12491211","article-title":"The production of p-cresol sulfate and indoxyl sulfate in vegetarians versus omnivores","volume":"7","author":"Patel","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.biochi.2026.05.009_bib22","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.kint.2017.02.011","article-title":"Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach","volume":"92","author":"Mishima","year":"2017","journal-title":"Kidney Int."},{"issue":"12","key":"10.1016\/j.biochi.2026.05.009_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10837","article-title":"The dietary fiber inulin slows progression of chronic kidney disease-mineral bone disorder (CKD-MBD) in a rat model of CKD","volume":"7","author":"Biruete","year":"2023","journal-title":"JBMR Plus"},{"issue":"2","key":"10.1016\/j.biochi.2026.05.009_bib24","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1021\/bi901786x","article-title":"The uremic toxin 3-indoxyl sulfate is a potent endogenous agonist for the human aryl hydrocarbon receptor","volume":"49","author":"Schroeder","year":"2010","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.biochi.2026.05.009_bib25","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/ki.2013.133","article-title":"Indolic uremic solutes increase tissue factor production in endothelial cells by the aryl hydrocarbon receptor pathway","volume":"84","author":"Gondouin","year":"2013","journal-title":"Kidney Int."},{"issue":"7","key":"10.1016\/j.biochi.2026.05.009_bib26","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1097\/01.ASN.0000022017.96399.B2","article-title":"Role of organic anion transporters in the tubular transport of indoxyl sulfate and the induction of its nephrotoxicity","volume":"13","author":"Enomoto","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1\u20132","key":"10.1016\/j.biochi.2026.05.009_bib27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0014-2999(03)01530-9","article-title":"Interactions of human organic anion as well as cation transporters with indoxyl sulfate","volume":"466","author":"Enomoto","year":"2003","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.biochi.2026.05.009_bib28","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1007\/s40618-024-02371-w","article-title":"Endocrine disruptors, aryl hydrocarbon receptor and cortisol secretion","volume":"47","author":"Pecori Giraldi","year":"2024","journal-title":"J. Endocrinol. Investig."},{"issue":"1","key":"10.1016\/j.biochi.2026.05.009_bib29","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12958-025-01401-3","article-title":"The aryl hydrocarbon receptor: a new frontier in male reproductive system","volume":"23","author":"Bustani","year":"2025","journal-title":"Reprod. Biol. Endocrinol."},{"issue":"3","key":"10.1016\/j.biochi.2026.05.009_bib30","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/17425255.2019.1569627","article-title":"Chemical activation of estrogen and aryl hydrocarbon receptor signaling pathways and their interaction in toxicology and metabolism","volume":"15","author":"Tarnow","year":"2019","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"7","key":"10.1016\/j.biochi.2026.05.009_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/toxins10070280","article-title":"Indoxyl sulfate, a uremic toxin, stimulates reactive oxygen species production and erythrocyte cell death supposedly by an organic anion transporter 2 (OAT2) and NADPH oxidase activity-dependent pathways","volume":"10","author":"Dias","year":"2018","journal-title":"Toxins"},{"issue":"21","key":"10.1016\/j.biochi.2026.05.009_bib32","doi-asserted-by":"crossref","first-page":"20340","DOI":"10.1074\/jbc.M412081200","article-title":"Transcriptional regulation of NF-E2 p45-related factor (NRF2) expression by the aryl hydrocarbon receptor-xenobiotic response element signaling pathway: direct cross-talk between phase I and II drug-metabolizing enzymes","volume":"280","author":"Miao","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biochi.2026.05.009_bib33","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bcp.2018.11.021","article-title":"Human AHR functions in vascular tissue: pro- and anti-inflammatory responses of AHR agonists in atherosclerosis","volume":"159","author":"Bock","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biochi.2026.05.009_bib34","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bcp.2019.06.015","article-title":"Aryl hydrocarbon receptor (AHR): from selected human target genes and crosstalk with transcription factors to multiple AHR functions","volume":"168","author":"Bock","year":"2019","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.biochi.2026.05.009_bib35","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1053\/j.gastro.2011.04.007","article-title":"Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract","volume":"141","author":"Monteleone","year":"2011","journal-title":"Gastroenterology"},{"issue":"566","key":"10.1016\/j.biochi.2026.05.009_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba0624","article-title":"Aryl hydrocarbon receptor ligand production by the gut microbiota is decreased in celiac disease leading to intestinal inflammation","volume":"12","author":"Lamas","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biochi.2026.05.009_bib37","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.freeradbiomed.2013.08.005","article-title":"Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation","volume":"65","author":"Hyeon","year":"2013","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.biochi.2026.05.009_bib38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00774-020-01162-6","article-title":"Osteoclast differentiation by RANKL and OPG signaling pathways","volume":"39","author":"Udagawa","year":"2021","journal-title":"J. Bone Miner. Metabol."},{"key":"10.1016\/j.biochi.2026.05.009_bib39","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.semcdb.2021.05.014","article-title":"Interaction between bone and immune cells: implications for postmenopausal osteoporosis","volume":"123","author":"Fischer","year":"2022","journal-title":"Semin. Cell Dev. Biol."},{"issue":"18","key":"10.1016\/j.biochi.2026.05.009_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21186654","article-title":"Aryl Hydrocarbon Receptor (AHR) ligands as selective AHR modulators (SAhRMs)","volume":"21","author":"Safe","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biochi.2026.05.009_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010374","article-title":"Anti-aging physiological roles of aryl hydrocarbon receptor and its dietary regulators","volume":"22","author":"Serna","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.biochi.2026.05.009_bib42","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.kint.2017.11.010","article-title":"Aryl hydrocarbon receptor is activated in patients and mice with chronic kidney disease","volume":"93","author":"Dou","year":"2018","journal-title":"Kidney Int."},{"key":"10.1016\/j.biochi.2026.05.009_bib43","doi-asserted-by":"crossref","DOI":"10.1177\/11786469241246674","article-title":"The role of aryl hydrocarbon receptor in bone biology","volume":"17","author":"Vyavahare","year":"2024","journal-title":"Int. J. Tryptophan Res."},{"key":"10.1016\/j.biochi.2026.05.009_bib44","article-title":"Functions of the aryl hydrocarbon receptor (AHR) beyond the canonical AHR\/ARNT signaling pathway","volume":"208","author":"Sondermann","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"10","key":"10.1016\/j.biochi.2026.05.009_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21103486","article-title":"Concentration and duration of indoxyl sulfate exposure affects osteoclastogenesis by regulating NFATc1 via aryl hydrocarbon receptor","volume":"21","author":"Liu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"20","key":"10.1016\/j.biochi.2026.05.009_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21207483","article-title":"Resveratrol rescue indoxyl sulfate-induced deterioration of osteoblastogenesis via the aryl Hydrocarbon receptor\/MAPK pathway","volume":"21","author":"Liu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.biochi.2026.05.009_bib47","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1101\/gad.13.8.1025","article-title":"A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development","volume":"13","author":"Ducy","year":"1999","journal-title":"Genes Dev."},{"issue":"3","key":"10.1016\/j.biochi.2026.05.009_bib48","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.kint.2019.09.029","article-title":"Temporal and tissue-specific activation of aryl hydrocarbon receptor in discrete mouse models of kidney disease","volume":"97","author":"Walker","year":"2020","journal-title":"Kidney Int."},{"issue":"12","key":"10.1016\/j.biochi.2026.05.009_bib49","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.4049\/jimmunol.1600822","article-title":"The nuclear receptor AhR controls bone homeostasis by regulating osteoclast differentiation via the RANK\/c-Fos signaling axis","volume":"197","author":"Izawa","year":"2016","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.biochi.2026.05.009_bib50","doi-asserted-by":"crossref","first-page":"357","DOI":"10.7326\/0003-4819-78-3-357","article-title":"Skeletal resistance to parathyroid hormone in renal failure. Studies in 105 human subjects","volume":"78","author":"Massry","year":"1973","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.biochi.2026.05.009_bib51","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.bone.2015.06.010","article-title":"Indoxyl sulfate exacerbates low bone turnover induced by parathyroidectomy in young adult rats","volume":"79","author":"Hirata","year":"2015","journal-title":"Bone"},{"issue":"8","key":"10.1016\/j.biochi.2026.05.009_bib52","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/2211-5463.12258","article-title":"Indoxyl sulfate, a uremic toxin in chronic kidney disease, suppresses both bone formation and bone resorption","volume":"7","author":"Watanabe","year":"2017","journal-title":"FEBS Open Bio"},{"issue":"8","key":"10.1016\/j.biochi.2026.05.009_bib53","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/sj.ki.5002097","article-title":"Indoxyl sulfate induces skeletal resistance to parathyroid hormone in cultured osteoblastic cells","volume":"71","author":"Nii-Kono","year":"2007","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.biochi.2026.05.009_bib54","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1093\/ndt\/gfr647","article-title":"Indoxyl sulphate inhibits osteoclast differentiation and function","volume":"27","author":"Mozar","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.biochi.2026.05.009_bib55","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev-physiol-021119-034332","article-title":"The osteocyte: new insights","volume":"82","author":"Robling","year":"2020","journal-title":"Annu. Rev. Physiol."},{"issue":"1","key":"10.1016\/j.biochi.2026.05.009_bib56","doi-asserted-by":"crossref","DOI":"10.1093\/jbmrpl\/ziae136","article-title":"The uremic toxin indoxyl sulfate decreases osteocyte RANKL\/OPG and increases Wnt inhibitor RNA expression that is reversed by PTH","volume":"9","author":"Chen","year":"2025","journal-title":"JBMR Plus"},{"issue":"7","key":"10.1016\/j.biochi.2026.05.009_bib57","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/jbmr.4574","article-title":"Calcimimetics alter periosteal and perilacunar bone matrix composition and material properties in early chronic kidney disease","volume":"37","author":"Damrath","year":"2022","journal-title":"J. Bone Miner. Res."},{"issue":"12","key":"10.1016\/j.biochi.2026.05.009_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22126563","article-title":"Paracrine kynurenic pathway activation in the bone of young uremic rats can antagonize anabolic effects of PTH on bone turnover and strength through the disruption of PTH-dependent molecular signaling","volume":"22","author":"Pawlak","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.biochi.2026.05.009_bib59","first-page":"4236","article-title":"AST-120 improved uremic pruritus by lowering indoxyl sulfate and inflammatory cytokines in hemodialysis patients","volume":"16","author":"Wu","year":"2024","journal-title":"Aging (Albany NY)"},{"issue":"2","key":"10.1016\/j.biochi.2026.05.009_bib60","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.bone.2013.07.037","article-title":"Accumulated uremic toxins attenuate bone mechanical properties in rats with chronic kidney disease","volume":"57","author":"Iwasaki","year":"2013","journal-title":"Bone"},{"issue":"11","key":"10.1016\/j.biochi.2026.05.009_bib61","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.chembiol.2023.07.015","article-title":"Mechanism-based inhibition of gut microbial tryptophanases reduces serum indoxyl sulfate","volume":"30","author":"Graboski","year":"2023","journal-title":"Cell Chem. Biol."}],"container-title":["Biochimie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908426001185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908426001185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T19:39:30Z","timestamp":1787427570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300908426001185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":61,"alternative-id":["S0300908426001185"],"URL":"https:\/\/doi.org\/10.1016\/j.biochi.2026.05.009","relation":{},"ISSN":["0300-9084"],"issn-type":[{"value":"0300-9084","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gut-derived uremic toxin indoxyl sulfate and aryl hydrocarbon receptor in renal osteodystrophy","name":"articletitle","label":"Article Title"},{"value":"Biochimie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biochi.2026.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}